Table 1.

Newly developed advanced schistosomiasis (NDAS) patients identified by historical survey, liver B-ultrasound scan and serological examination, 30 healthy people were selected as negative controls.

Case	Number	Age	HA (ng/mL)	GGT (U/L)	B-ultrasound	Time interval between the last chemotherapy and advanced Schistosomiasis determined (years)
NDAS	30	68.49 ± 7.10	484.97 ± 458.07	168.07 ± 130.35	Network-like changes in liver and portal vein widening	35.6 ± 5.04
Healthy control	30	68.79 ± 4.10	50.67 ± 16.46	32.53 ± 7.69	No obvious abnormality in the liver	–